X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4485) 4485
Publication (264) 264
Book Review (12) 12
Book Chapter (6) 6
Conference Proceeding (1) 1
Magazine Article (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
dinoprost - analogs & derivatives (2941) 2941
female (2754) 2754
animals (2717) 2717
humans (2008) 2008
male (1937) 1937
index medicus (1126) 1126
oxidative stress (1105) 1105
dinoprost - pharmacology (1056) 1056
dinoprost - blood (909) 909
pregnancy (909) 909
adult (831) 831
middle aged (776) 776
dinoprost - metabolism (774) 774
rats (727) 727
dinoprost - urine (501) 501
aged (476) 476
time factors (452) 452
progesterone - blood (451) 451
cattle (403) 403
in vitro techniques (402) 402
dose-response relationship, drug (391) 391
reproductive biology (386) 386
dinoprost - administration & dosage (365) 365
dinoprost (361) 361
pharmacology & pharmacy (333) 333
endocrinology & metabolism (332) 332
mice (325) 325
biochemistry & molecular biology (315) 315
prostaglandins (313) 313
cells, cultured (303) 303
oxidative stress - drug effects (293) 293
inflammation (291) 291
progesterone (286) 286
lipid peroxidation (281) 281
veterinary sciences (280) 280
biomarkers - blood (277) 277
lipid-peroxidation (275) 275
in-vivo (265) 265
isoprostanes (262) 262
cattle - physiology (261) 261
dinoprost - analysis (255) 255
f2-isoprostanes (249) 249
oxidative stress - physiology (233) 233
agriculture, dairy & animal science (232) 232
rats, sprague-dawley (221) 221
prostaglandins f - pharmacology (204) 204
dinoprost - biosynthesis (196) 196
peripheral vascular disease (194) 194
expression (190) 190
nitric oxide (184) 184
nitric-oxide (179) 179
prostaglandin (178) 178
swine (177) 177
corpus luteum - drug effects (174) 174
estrous-cycle (174) 174
rats, wistar (174) 174
antioxidants (173) 173
biomarkers - urine (171) 171
adolescent (170) 170
plasma (168) 168
biomarkers (167) 167
cardiac & cardiovascular systems (166) 166
insemination, artificial - veterinary (165) 165
rabbits (165) 165
ophthalmology (164) 164
prostaglandins f - blood (164) 164
physiology (162) 162
intraocular pressure - drug effects (161) 161
muscle, smooth, vascular - drug effects (161) 161
dinoprostone - pharmacology (159) 159
dogs (159) 159
analysis (155) 155
case-control studies (154) 154
8-isoprostane (153) 153
cell biology (153) 153
muscle contraction - drug effects (152) 152
research (152) 152
physiological aspects (150) 150
kinetics (149) 149
radioimmunoassay (148) 148
indomethacin - pharmacology (145) 145
prostaglandins f, synthetic - pharmacology (141) 141
cells (139) 139
disease models, animal (139) 139
vasoconstrictor agents - pharmacology (139) 139
estradiol - blood (138) 138
risk factors (137) 137
dinoprostone - metabolism (136) 136
hypertension (135) 135
sheep (134) 134
nitric oxide - metabolism (133) 133
antioxidants - pharmacology (132) 132
respiratory system (132) 132
oxytocin - pharmacology (130) 130
dinoprostone - analogs & derivatives (129) 129
dinoprostone (128) 128
estrus (128) 128
vasoconstriction - drug effects (128) 128
estradiol - pharmacology (126) 126
ovulation (126) 126
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4365) 4365
Japanese (99) 99
German (36) 36
Chinese (29) 29
Russian (20) 20
French (12) 12
Polish (8) 8
Czech (4) 4
Romanian (4) 4
Spanish (3) 3
Italian (2) 2
Slovak (2) 2
Bulgarian (1) 1
Danish (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American Academy of Dermatology, ISSN 0190-9622, 2014, Volume 72, Issue 4, pp. 712 - 716
Prostaglandin F2α analogs, commonly prescribed for glaucoma treatment, have been shown to induce side effects such as cutaneous hypertrichosis and... 
Dermatology | androgenic alopecia | latanoprost | bimatoprost | prostaglandin | glaucoma | prostaglandin F2α analog | vitiligo | travoprost | alopecia areata | Glaucoma | Vitiligo | Androgenic alopecia | Prostaglandin | Prostaglandin F2α analog | Alopecia areata | Bimatoprost | Latanoprost | Travoprost | Key words alopecia areata | prostaglandin F2 alpha analog | OPHTHALMIC SOLUTION | EFFICACY | LATANOPROST TREATMENT | IRIDIAL PIGMENTATION | IRIS PIGMENTATION | HUMAN MELANOCYTES | DERMATOLOGY | TOPICAL BIMATOPROST | PATTERN ANDROGENETIC ALOPECIA | AREATA | HAIR-GROWTH | Single-Blind Method | Eyelashes - drug effects | Humans | Adrenal Cortex Hormones - therapeutic use | Melanins - biosynthesis | Dinoprost - physiology | Prostaglandins F, Synthetic - administration & dosage | Amides - adverse effects | Retrospective Studies | Drug Evaluation, Preclinical | Disease Models, Animal | Hyperpigmentation - chemically induced | Cloprostenol - adverse effects | Double-Blind Method | Glaucoma - drug therapy | Amides - therapeutic use | Prostaglandins F, Synthetic - adverse effects | Prostaglandins F, Synthetic - therapeutic use | Cloprostenol - analogs & derivatives | Randomized Controlled Trials as Topic | Hair Follicle - drug effects | Animals | Alopecia - drug therapy | Hypertrichosis - chemically induced | Hypopigmentation - drug therapy | Cloprostenol - therapeutic use | Mice | Adrenal Cortex Hormones - administration & dosage
Journal Article
Journal Article
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 01/2015, Volume 21, Issue 38, pp. 5558 - 5572
A major trend in fine chemicals and pharmaceuticals is the synthesis of molecules with increased complexity. This trend translates the aim of organic syntheses... 
Heterogeneous catalysis | Prostaglandins | Cloprostenol | Hydrogenation | Diastereoselectivity | Chiral modifier | Animals | Dinoprost - chemistry | Stereoisomerism | Humans | Dinoprost - analogs & derivatives | Molecular Structure | Catalysis | Dinoprost - metabolism
Journal Article
Journal of Veterinary Pharmacology and Therapeutics, ISSN 0140-7783, 04/2015, Volume 38, Issue 2, pp. 105 - 112
A distinguishing feature of the most common types of glaucoma is an increased intra‐ocular pressure (IOP), which has a damaging effect on optic nerve axons,... 
Cats | Animals | Dog Diseases - drug therapy | Dinoprost - administration & dosage | Intraocular Pressure | Dogs | Cat Diseases - drug therapy | Glaucoma - drug therapy | Dinoprost - analogs & derivatives | Dinoprost - therapeutic use | Glaucoma - veterinary | Administration, Topical | Index Medicus
Journal Article
Clinical & Experimental Ophthalmology, ISSN 1442-6404, 11/2006, Volume 34, Issue 8, pp. 755 - 764
Background:  It is still uncertain whether travoprost has comparable or better efficacy compared with other prostaglandin analogues or timolol in patients with... 
open-angle | prostaglandin analogue | timolol | travoprost | ocular hypertension | glaucoma | open‐angle | Glaucoma | Prostaglandin analogue | Open-angle | Timolol | Ocular hypertension | Travoprost | ELEVATED INTRAOCULAR-PRESSURE | OPHTHALMIC SOLUTION | TOPICAL TRAVOPROST | CELL RESPONSES | HYPOTENSIVE EFFICACY | HEALTHY-SUBJECTS | FIXED COMBINATION | DRUG-TREATMENT | BIMATOPROST 0.03-PERCENT | OPHTHALMOLOGY | INTRACELLULAR CA2+ MOBILIZATION | Cloprostenol - adverse effects | Intraocular Pressure - drug effects | Humans | Middle Aged | Male | Amides - therapeutic use | Prostaglandins F, Synthetic - adverse effects | Antihypertensive Agents - therapeutic use | Lipids - therapeutic use | Prostaglandins F, Synthetic - therapeutic use | Antihypertensive Agents - adverse effects | Cloprostenol - analogs & derivatives | Glaucoma, Open-Angle - drug therapy | Ocular Hypertension - drug therapy | Randomized Controlled Trials as Topic | Female | Aged | Cloprostenol - therapeutic use | Dinoprost - analogs & derivatives | Dinoprost - therapeutic use | Timolol - therapeutic use | Bimatoprost | Timolol - adverse effects | Intraocular Pressure, drug effects | Comparative Study | Timolol, adverse effects | Dinoprost, therapeutic use | Prostaglandins F, Synthetic, therapeutic use | Timolol, therapeutic use | Glaucoma, Open-Angle, drug therapy | Dinoprost, analogs and derivatives | Lipids, therapeutic use | Randomized Controlled Trials | Cloprostenol, therapeutic use | Prostaglandins F, Synthetic, adverse effects | Amides, therapeutic use | Cloprostenol, adverse effects | Ocular Hypertension, drug therapy | Cloprostenol, analogs and derivatives | Hypertension | Care and treatment | Analysis | Ophthalmic drugs | Clinical trials | Ophthalmology
Journal Article
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2013, Volume 38, Issue 9, pp. 1698 - 1708
Journal Article